{"id":877,"date":"2024-10-21T21:23:46","date_gmt":"2024-10-21T21:23:46","guid":{"rendered":"http:\/\/alliance-co2-solutions.org\/?p=877"},"modified":"2024-10-21T21:23:46","modified_gmt":"2024-10-21T21:23:46","slug":"aquaporumab-prevented-the-forming-of-nmo-lesions-in-spinal-cord-pieces-and-in-mice-igg-degrading-enzyme-ides-potential-remedies-supplement-activation-eculizumab-a-supplement-c1-targeted","status":"publish","type":"post","link":"https:\/\/alliance-co2-solutions.org\/?p=877","title":{"rendered":"\ufeffAquaporumab prevented the forming of NMO lesions in spinal-cord pieces and in mice IgG-degrading enzyme IdeS; potential remedies), supplement activation (eculizumab, a supplement C1-targeted monoclonal antibody (mAb) as well as the C1 esterase inhibitor; potential remedies), substances that disrupt the forming of orthogonal arrays of contaminants (OAPs; a potential treatment), supplement inhibitors (Compact disc46, Compact disc55 and Compact disc59; potential remedies) and inhibitors of leukocyte activity (sivelestat and cetirizine; potential remedies)"},"content":{"rendered":"

\ufeffAquaporumab prevented the forming of NMO lesions in spinal-cord pieces and in mice IgG-degrading enzyme IdeS; potential remedies), supplement activation (eculizumab, a supplement C1-targeted monoclonal antibody (mAb) as well as the C1 esterase inhibitor; potential remedies), substances that disrupt the forming of orthogonal arrays of contaminants (OAPs; a potential treatment), supplement inhibitors (Compact disc46, Compact disc55 and Compact disc59; potential remedies) and inhibitors of leukocyte activity (sivelestat and cetirizine; potential remedies). certainly are a course of membrane drinking water channels whose principal function is to facilitate the passive transportation of water over the plasma membrane from the cell in response to osmotic gradients that are manufactured by the dynamic transportation of solutes. Aquaglyceroporins, which type a subset from the 13 mammalian AQPs, also facilitate the passive transportation of glycerol and other little solutes such as for example urea and skin tightening and perhaps. As we below discuss, the water-selective AQPs get excited about many biological features, including transepithelial liquid transportation, cell migration, brain neuroexcitation and oedema. The aquaglyceroporins get excited about cell proliferation, adipocyte fat burning capacity and epidermal fluid retention. As highlighted right here, data from AQP-knockout mice and from human beings with loss-of-function mutations in AQPs claim that modulators of AQP function may possess broad clinical signs, including in nephrology (for the treating oedema and hypertension), neurology (for the treating brain bloating and epilepsy), oncology (for the treating tumour angiogenesis and proliferation), ophthalmology (for the treating corneal and zoom lens transparency aswell as glaucoma) and in the treating weight problems and dermatological signs (namely, epidermal proliferation and hydration. Furthermore, two human illnesses that are associated with aqua-porins (referred to as aquaporinopathies) present medication development possibilities, including potential remedies: ROR gamma modulator 1 nephrogenic diabetes insipidus (NDI), which is normally due to loss-of-function mutations; and neuromyelitis optica (NMO), which is normally due to the current presence of auto-antibodies against AQP4. Right here, we review the function and framework of AQPs, the data to get AQPs as medication targets, aswell as issues and improvement in the breakthrough of AQP-targeted little substances, gene and biologics therapies. Although there is normally compelling proof from research using knockout mice that AQPs are medication targets, improvement in the breakthrough of AQP modulators continues to be slow, partly because current initiatives to recognize inhibitors are hampered by issues in testing assays and in concentrating on the small, pore-containing AQP molecule. AQP framework and function There’s a massive amount information obtainable about the molecular framework of AQPs (analyzed in REFS 1,2), that could facilitate the discovery of AQP-targeted small molecules potentially. AQPs are arranged as tetramers on membranes (FIG. 1a). At least among the AQPs, ROR gamma modulator 1 AQP4, can associate into higher-order supramolecular assemblies referred to as orthogonal arrays of contaminants, where AQP4 tetramers type square arrays that are stabilized with the connections of aminoterminal residues in the monomeric systems3C5. Early, low-resolution AQP buildings resolved by electron crystallography consist of AQP0 (also called MIP; Proteins Data Loan provider (PDB) rules: 1SOR and 2B6O), AQP1 (PDB rules: 1IH5, 1FQY and 1H6I) and AQP4 (PDB code: 2D57). High-resolution X-ray crystal buildings are for sale to AQP0 (PDB rules: 1YMG and 2B6P), AQP1 (PDB code: 1J4N), AQP4 (PDB code: 3GD8) and AQP5 (PDB code: 3D9S). However the low-resolution buildings garnered a knowledge of the overall topology of AQPs, the ROR gamma modulator 1 high-resolution buildings provided greater understanding in to the atomic-level systems of drinking water and solute conduction and of proton and\/or ion exclusion, and offer a basis for digital screening process and molecular dynamics simulations. X-ray and Electron crystal diffraction buildings for many non-mammalian AQPs are also resolved, like the bacterial aquaporin AqpZ (PDB rules: 1RC2 and 2ABM) as well as the glycerol facilitator GlpF (PDB rules: 1LDA, 1LDI and 1FX8), aswell as malarial AQP (PfAQP; PDB code: 3C02). Open up in another window Amount 1 Framework of aquaporinsa | A high view from the extracellular encounter of the aquaporin 1 (AQP1) homotetramer, with monomers labelled 1C4, predicated on the X-ray framework of bovine AQP1 (Proteins Data Loan provider (PDB) code: 1J4N). The tetrameric framework was modelled with the interactive PDBePISA (proteins, interfaces, buildings and assemblies) device. b | A schematic of AQP membrane ROR gamma modulator 1<\/a> topography. c | Framework from the bovine AQP1 monomeric device, which shows essential helical domains (labelled M1CM8) and hooking up linkers (labelled aCe). d | A GADD45B<\/a> watch in to the extracellular vestibule of bovine AQP1. The constriction area (in green) comprises of aromatic and arginine residues (referred to as the ar\/R constriction; residues Phe58, His182 and Arg197); extracellular Asn-Pro-Ala (NPA) residues (Asn194,.<\/p>\n","protected":false},"excerpt":{"rendered":"

\ufeffAquaporumab prevented the forming of NMO lesions in spinal-cord pieces and in mice IgG-degrading enzyme IdeS; potential remedies), supplement activation (eculizumab, a supplement C1-targeted monoclonal antibody (mAb) as well as the C1 esterase inhibitor; potential remedies), substances that disrupt the forming of orthogonal arrays of contaminants (OAPs; a potential treatment), supplement inhibitors (Compact disc46, Compact […]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[19],"tags":[],"class_list":["post-877","post","type-post","status-publish","format-standard","hentry","category-endothelin-non-selective","no-featured-image"],"yoast_head":"\n\ufeffAquaporumab prevented the forming of NMO lesions in spinal-cord pieces and in mice IgG-degrading enzyme IdeS; potential remedies), supplement activation (eculizumab, a supplement C1-targeted monoclonal antibody (mAb) as well as the C1 esterase inhibitor; potential remedies), substances that disrupt the forming of orthogonal arrays of contaminants (OAPs; a potential treatment), supplement inhibitors (Compact disc46, Compact disc55 and Compact disc59; potential remedies) and inhibitors of leukocyte activity (sivelestat and cetirizine; potential remedies) - MCT1 inhibitor in Alzheimer\u2019s disease<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/alliance-co2-solutions.org\/?p=877\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"\ufeffAquaporumab prevented the forming of NMO lesions in spinal-cord pieces and in mice IgG-degrading enzyme IdeS; potential remedies), supplement activation (eculizumab, a supplement C1-targeted monoclonal antibody (mAb) as well as the C1 esterase inhibitor; potential remedies), substances that disrupt the forming of orthogonal arrays of contaminants (OAPs; a potential treatment), supplement inhibitors (Compact disc46, Compact disc55 and Compact disc59; potential remedies) and inhibitors of leukocyte activity (sivelestat and cetirizine; potential remedies) - MCT1 inhibitor in Alzheimer\u2019s disease\" \/>\n<meta property=\"og:description\" content=\"\ufeffAquaporumab prevented the forming of NMO lesions in spinal-cord pieces and in mice IgG-degrading enzyme IdeS; potential remedies), supplement activation (eculizumab, a supplement C1-targeted monoclonal antibody (mAb) as well as the C1 esterase inhibitor; potential remedies), substances that disrupt the forming of orthogonal arrays of contaminants (OAPs; a potential treatment), supplement inhibitors (Compact disc46, Compact […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/alliance-co2-solutions.org\/?p=877\" \/>\n<meta property=\"og:site_name\" content=\"MCT1 inhibitor in Alzheimer\u2019s disease\" \/>\n<meta property=\"article:published_time\" content=\"2024-10-21T21:23:46+00:00\" \/>\n<meta name=\"author\" content=\"editor\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"editor\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/alliance-co2-solutions.org\\\/?p=877#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/alliance-co2-solutions.org\\\/?p=877\"},\"author\":{\"name\":\"editor\",\"@id\":\"https:\\\/\\\/alliance-co2-solutions.org\\\/#\\\/schema\\\/person\\\/a2b0326f36b85c0b32bd36cafe75b703\"},\"headline\":\"\ufeffAquaporumab prevented the forming of NMO lesions in spinal-cord pieces and in mice IgG-degrading enzyme IdeS; potential remedies), supplement activation (eculizumab, a supplement C1-targeted monoclonal antibody (mAb) as well as the C1 esterase inhibitor; potential remedies), substances that disrupt the forming of orthogonal arrays of contaminants (OAPs; a potential treatment), supplement inhibitors (Compact disc46, Compact disc55 and Compact disc59; potential remedies) and inhibitors of leukocyte activity (sivelestat and cetirizine; potential remedies)\",\"datePublished\":\"2024-10-21T21:23:46+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/alliance-co2-solutions.org\\\/?p=877\"},\"wordCount\":839,\"articleSection\":[\"Endothelin, Non-Selective\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/alliance-co2-solutions.org\\\/?p=877\",\"url\":\"https:\\\/\\\/alliance-co2-solutions.org\\\/?p=877\",\"name\":\"\ufeffAquaporumab prevented the forming of NMO lesions in spinal-cord pieces and in mice IgG-degrading enzyme IdeS; potential remedies), supplement activation (eculizumab, a supplement C1-targeted monoclonal antibody (mAb) as well as the C1 esterase inhibitor; potential remedies), substances that disrupt the forming of orthogonal arrays of contaminants (OAPs; a potential treatment), supplement inhibitors (Compact disc46, Compact disc55 and Compact disc59; potential remedies) and inhibitors of leukocyte activity (sivelestat and cetirizine; potential remedies) - MCT1 inhibitor in Alzheimer\u2019s disease\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/alliance-co2-solutions.org\\\/#website\"},\"datePublished\":\"2024-10-21T21:23:46+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/alliance-co2-solutions.org\\\/#\\\/schema\\\/person\\\/a2b0326f36b85c0b32bd36cafe75b703\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/alliance-co2-solutions.org\\\/?p=877#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/alliance-co2-solutions.org\\\/?p=877\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/alliance-co2-solutions.org\\\/?p=877#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/alliance-co2-solutions.org\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"\ufeffAquaporumab prevented the forming of NMO lesions in spinal-cord pieces and in mice IgG-degrading enzyme IdeS; potential remedies), supplement activation (eculizumab, a supplement C1-targeted monoclonal antibody (mAb) as well as the C1 esterase inhibitor; potential remedies), substances that disrupt the forming of orthogonal arrays of contaminants (OAPs; a potential treatment), supplement inhibitors (Compact disc46, Compact disc55 and Compact disc59; potential remedies) and inhibitors of leukocyte activity (sivelestat and cetirizine; potential remedies)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/alliance-co2-solutions.org\\\/#website\",\"url\":\"https:\\\/\\\/alliance-co2-solutions.org\\\/\",\"name\":\"MCT1 inhibitor in Alzheimer\u2019s disease\",\"description\":\"Just another WordPress site\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/alliance-co2-solutions.org\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/alliance-co2-solutions.org\\\/#\\\/schema\\\/person\\\/a2b0326f36b85c0b32bd36cafe75b703\",\"name\":\"editor\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/f4dcc14beeefbe081cae764d647559acc93d9c15b285756a5f3113c02d044c11?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/f4dcc14beeefbe081cae764d647559acc93d9c15b285756a5f3113c02d044c11?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/f4dcc14beeefbe081cae764d647559acc93d9c15b285756a5f3113c02d044c11?s=96&d=mm&r=g\",\"caption\":\"editor\"},\"sameAs\":[\"http:\\\/\\\/alliance-co2-solutions.org\"],\"url\":\"https:\\\/\\\/alliance-co2-solutions.org\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"\ufeffAquaporumab prevented the forming of NMO lesions in spinal-cord pieces and in mice IgG-degrading enzyme IdeS; potential remedies), supplement activation (eculizumab, a supplement C1-targeted monoclonal antibody (mAb) as well as the C1 esterase inhibitor; potential remedies), substances that disrupt the forming of orthogonal arrays of contaminants (OAPs; a potential treatment), supplement inhibitors (Compact disc46, Compact disc55 and Compact disc59; potential remedies) and inhibitors of leukocyte activity (sivelestat and cetirizine; potential remedies) - MCT1 inhibitor in Alzheimer\u2019s disease","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/alliance-co2-solutions.org\/?p=877","og_locale":"en_US","og_type":"article","og_title":"\ufeffAquaporumab prevented the forming of NMO lesions in spinal-cord pieces and in mice IgG-degrading enzyme IdeS; potential remedies), supplement activation (eculizumab, a supplement C1-targeted monoclonal antibody (mAb) as well as the C1 esterase inhibitor; potential remedies), substances that disrupt the forming of orthogonal arrays of contaminants (OAPs; a potential treatment), supplement inhibitors (Compact disc46, Compact disc55 and Compact disc59; potential remedies) and inhibitors of leukocyte activity (sivelestat and cetirizine; potential remedies) - MCT1 inhibitor in Alzheimer\u2019s disease","og_description":"\ufeffAquaporumab prevented the forming of NMO lesions in spinal-cord pieces and in mice IgG-degrading enzyme IdeS; potential remedies), supplement activation (eculizumab, a supplement C1-targeted monoclonal antibody (mAb) as well as the C1 esterase inhibitor; potential remedies), substances that disrupt the forming of orthogonal arrays of contaminants (OAPs; a potential treatment), supplement inhibitors (Compact disc46, Compact […]","og_url":"https:\/\/alliance-co2-solutions.org\/?p=877","og_site_name":"MCT1 inhibitor in Alzheimer\u2019s disease","article_published_time":"2024-10-21T21:23:46+00:00","author":"editor","twitter_card":"summary_large_image","twitter_misc":{"Written by":"editor","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/alliance-co2-solutions.org\/?p=877#article","isPartOf":{"@id":"https:\/\/alliance-co2-solutions.org\/?p=877"},"author":{"name":"editor","@id":"https:\/\/alliance-co2-solutions.org\/#\/schema\/person\/a2b0326f36b85c0b32bd36cafe75b703"},"headline":"\ufeffAquaporumab prevented the forming of NMO lesions in spinal-cord pieces and in mice IgG-degrading enzyme IdeS; potential remedies), supplement activation (eculizumab, a supplement C1-targeted monoclonal antibody (mAb) as well as the C1 esterase inhibitor; potential remedies), substances that disrupt the forming of orthogonal arrays of contaminants (OAPs; a potential treatment), supplement inhibitors (Compact disc46, Compact disc55 and Compact disc59; potential remedies) and inhibitors of leukocyte activity (sivelestat and cetirizine; potential remedies)","datePublished":"2024-10-21T21:23:46+00:00","mainEntityOfPage":{"@id":"https:\/\/alliance-co2-solutions.org\/?p=877"},"wordCount":839,"articleSection":["Endothelin, Non-Selective"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/alliance-co2-solutions.org\/?p=877","url":"https:\/\/alliance-co2-solutions.org\/?p=877","name":"\ufeffAquaporumab prevented the forming of NMO lesions in spinal-cord pieces and in mice IgG-degrading enzyme IdeS; potential remedies), supplement activation (eculizumab, a supplement C1-targeted monoclonal antibody (mAb) as well as the C1 esterase inhibitor; potential remedies), substances that disrupt the forming of orthogonal arrays of contaminants (OAPs; a potential treatment), supplement inhibitors (Compact disc46, Compact disc55 and Compact disc59; potential remedies) and inhibitors of leukocyte activity (sivelestat and cetirizine; potential remedies) - MCT1 inhibitor in Alzheimer\u2019s disease","isPartOf":{"@id":"https:\/\/alliance-co2-solutions.org\/#website"},"datePublished":"2024-10-21T21:23:46+00:00","author":{"@id":"https:\/\/alliance-co2-solutions.org\/#\/schema\/person\/a2b0326f36b85c0b32bd36cafe75b703"},"breadcrumb":{"@id":"https:\/\/alliance-co2-solutions.org\/?p=877#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/alliance-co2-solutions.org\/?p=877"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/alliance-co2-solutions.org\/?p=877#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/alliance-co2-solutions.org\/"},{"@type":"ListItem","position":2,"name":"\ufeffAquaporumab prevented the forming of NMO lesions in spinal-cord pieces and in mice IgG-degrading enzyme IdeS; potential remedies), supplement activation (eculizumab, a supplement C1-targeted monoclonal antibody (mAb) as well as the C1 esterase inhibitor; potential remedies), substances that disrupt the forming of orthogonal arrays of contaminants (OAPs; a potential treatment), supplement inhibitors (Compact disc46, Compact disc55 and Compact disc59; potential remedies) and inhibitors of leukocyte activity (sivelestat and cetirizine; potential remedies)"}]},{"@type":"WebSite","@id":"https:\/\/alliance-co2-solutions.org\/#website","url":"https:\/\/alliance-co2-solutions.org\/","name":"MCT1 inhibitor in Alzheimer\u2019s disease","description":"Just another WordPress site","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/alliance-co2-solutions.org\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/alliance-co2-solutions.org\/#\/schema\/person\/a2b0326f36b85c0b32bd36cafe75b703","name":"editor","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/f4dcc14beeefbe081cae764d647559acc93d9c15b285756a5f3113c02d044c11?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/f4dcc14beeefbe081cae764d647559acc93d9c15b285756a5f3113c02d044c11?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/f4dcc14beeefbe081cae764d647559acc93d9c15b285756a5f3113c02d044c11?s=96&d=mm&r=g","caption":"editor"},"sameAs":["http:\/\/alliance-co2-solutions.org"],"url":"https:\/\/alliance-co2-solutions.org\/?author=1"}]}},"_links":{"self":[{"href":"https:\/\/alliance-co2-solutions.org\/index.php?rest_route=\/wp\/v2\/posts\/877","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/alliance-co2-solutions.org\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/alliance-co2-solutions.org\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/alliance-co2-solutions.org\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/alliance-co2-solutions.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=877"}],"version-history":[{"count":1,"href":"https:\/\/alliance-co2-solutions.org\/index.php?rest_route=\/wp\/v2\/posts\/877\/revisions"}],"predecessor-version":[{"id":878,"href":"https:\/\/alliance-co2-solutions.org\/index.php?rest_route=\/wp\/v2\/posts\/877\/revisions\/878"}],"wp:attachment":[{"href":"https:\/\/alliance-co2-solutions.org\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=877"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/alliance-co2-solutions.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=877"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/alliance-co2-solutions.org\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=877"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}